Notice Filed with SOS |
06/15/2022 |
Rule |
ProposedRuleAttach2022-00283.doc
|
Statutory Authority |
§§ 10-16-1410(3) and 10-16-1403(5), C.R.S. |
Description of Subjects/Issues |
New regulation for the Prescription Drug Affordability Board including reporting requirements for use of savings |
Purpose/Objective of Rule |
The purpose of this part 5 is to establish a formula and process for carriers issuing health benefit plans to calculate savings attributable to the establishment of an upper payment limit (UPL) by the Prescription Drug Affordability Board (Board) and document their use of savings for the purposes of complying with section 10-16-1410(1), C.R.S., and establish the process by which state entities and carriers that issue a health benefit plan or optional participating plans shall submit reports to the Board describing savings achieved during the preceding plan year pursuant to section 10-16-1410(2), C.R.S. |
Submitted in response to issues raised by COLS/OLLS? |
No
|
Is this rule adopted in response to recent legislation? |
No
|
Hearing Date |
07/15/2022 |
Hearing Time |
10:00 AM |
Hearing Location |
Webinar or 1560 Broadway, STE 850, Denver CO 80202 |
Contact Name |
Jill Mullen |
Contact Title |
Policy Advisor |
Contact Telephone |
720-5564952 |
Contact email |
jill.mullen@state.co.us |